Literature DB >> 20345480

Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection.

Hua Huang1, Xiao-Fei Zhang, Hai-Jun Zhou, Yu-Hua Xue, Qiong-Zhu Dong, Qing-Hai Ye, Lun-Xiu Qin.   

Abstract

Osteopontin (OPN) plays an important role in the development, invasion, and metastasis of malignancies. Recently, several studies have reported that OPN enhances chemoresistance in small-cell lung cancer and breast cancer by blocking caspase-9 and caspase-3-dependent cell apoptosis. The aim of this study was to assess the value of OPN and caspase-3 for predicting tumor recurrence after curative resection in hepatocellular carcinoma (HCC) patients. We found that OPN expression increased concordantly with increasing metastatic potential in human HCC cell lines, whereas caspase-3 expression declined. In a tumor tissue microarray immunohistochemical analysis, we found that patients with higher levels of OPN and lower levels of caspase-3 had a significantly poorer prognosis than patients with lower OPN and higher caspase-3 levels. The combination of OPN and caspase-3 expression thus served as an effective prognosticator. These findings suggest that OPN alone or in combination with caspase-3 may act as an independent indicator for HCC patients after curative resection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345480     DOI: 10.1111/j.1349-7006.2010.01524.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  27 in total

1.  Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

Authors:  Wanqiu Chen; Qingyi Ma; Hidenori Suzuki; Richard Hartman; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2011-01-27       Impact factor: 7.914

2.  Apoptotic effects of dipyrido [3,2-a:2',3'-c] phenazine (dppz) Au(III) complex against diethylnitrosamine/phenobarbital induced experimental hepatocarcinogenesis in rats.

Authors:  Neslihan Tekin; Mehmet C Ustuner; Fahrettin Akyuz; Cansu S Ozbayer; Ozlem Aydın; Kadriye Benkli; Dilek Burukoglu; Irfan Degirmenci; Hilmi Ozden
Journal:  Mol Biol Rep       Date:  2014-04-23       Impact factor: 2.316

3.  Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.

Authors:  Matthew A C Zapf; Anai N Kothari; Cynthia E Weber; Matthew L Arffa; Phillip Y Wai; Joseph Driver; Gopal N Gupta; Paul C Kuo; Zhiyong Mi
Journal:  Surgery       Date:  2015-07-17       Impact factor: 3.982

4.  A preliminary in vivo study of the effects of OPN on rat liver regeneration induced by partial hepatectomy.

Authors:  Gaiping Wang; Congcong Zhao; Shasha Chen; Xiaofang Li; Ling Zhang; Cuifang Chang; Cunshuan Xu
Journal:  Mol Biol Rep       Date:  2016-09-01       Impact factor: 2.316

Review 5.  Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Mei Wang
Journal:  World J Hepatol       Date:  2015-01-27

6.  Autophagy and Apoptosis Play Opposing Roles in Overall Survival of Esophageal Squamous Cell Carcinoma.

Authors:  Hsin-I Chen; Hung-Pei Tsai; Yi-Ting Chen; Shu-Chuan Tsao; Chee-Yin Chai
Journal:  Pathol Oncol Res       Date:  2016-03-15       Impact factor: 3.201

Review 7.  Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.

Authors:  Lunxiu Qin
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

8.  Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice.

Authors:  Soona Shin; Kirk J Wangensteen; Monica Teta-Bissett; Yue J Wang; Elham Mosleh-Shirazi; Elizabeth L Buza; Linda E Greenbaum; Klaus H Kaestner
Journal:  Hepatology       Date:  2016-05-28       Impact factor: 17.425

Review 9.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Authors:  Dong-Xing Cao; Zhi-Jie Li; Xiao-Ou Jiang; Yick Liang Lum; Ester Khin; Nikki P Lee; Guo-Hao Wu; John M Luk
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

10.  Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway.

Authors:  Xinxin Yu; Yan Zheng; Xuchao Zhu; Xiaomei Gao; Chaoqun Wang; Yuanyuan Sheng; Wei Cheng; Lunxiu Qin; Ning Ren; Huliang Jia; Qiongzhu Dong
Journal:  Oncol Lett       Date:  2018-08-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.